MMF-28270-44640
2 vaccinations
1 coded response
24 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 481 / MI
- Registered
- 2021-07-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-07
Dose 1 — Pfizer-BioNTech
-
2021-07-08
Registered in v-safe
- 2021-07-08
- 2021-07-09
- 2021-07-10
- 2021-07-11
- 2021-07-12
- 2021-07-13
- 2021-07-14
- 2021-07-21
-
2021-07-28
Dose 2 — Pfizer-BioNTech
- 2021-07-28
-
2021-07-29
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-07-30
- 2021-07-31
- 2021-08-01
- 2021-08-02
- 2021-08-03
- 2021-08-04
-
2021-08-11
Survey response — day 14, dose 2MedDRA: Fatigue, Rhinorrhoea — Feeling: FairFree text: Fatigue, runny noseMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-08-18
- 2021-08-25
- 2021-09-01
- 2021-09-08
- 2021-10-27
- 2022-01-28
- 2022-08-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-07 | Pfizer-BioNTech | No |
| 2 | 2021-07-28 | Pfizer-BioNTech | No |
Free text
Release 9 — day 14, dose 2
Symptoms: Fatigue, runny nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | ✓ | · | ✓ |
| SD | Rhinorrhoea | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release